Nihon Kohden Corp represents a strong commitment to innovation, quality, and patient-centric care. As a leading manufacturer of medical equipment, the company prioritizes the development and delivery of advanced solutions in the healthcare industry. With a corporate philosophy centered on "Quality First," Nihon Kohden Corp continuously strives to enhance patient outcomes and promote efficiency in medical settings. Through their dedication to technological advancements and customer satisfaction, Nihon Kohden Corp has established itself as a trusted provider of medical devices for hospitals and healthcare professionals worldwide.

Nihon Kohden Corp is primarily present in Japan, with its headquarters located in Tokyo. With a strong presence in the domestic market, the company operates globally and has expanded its business operations to many countries and regions worldwide. Nihon Kohden Corp has a widespread international presence, including subsidiaries and representative offices in various countries such as the United States, Germany, France, China, Brazil, and many more.

Nihon Kohden Corp, a leader in medical equipment manufacturing, has achieved numerous significant milestones throughout its history. The company, founded in 1951, has continuously innovated and provided cutting-edge medical technologies worldwide. Some notable milestones include the development of the first Japanese-made electronic diagnostic electrocardiograph (ECG), the introduction of wireless telemetry monitoring systems, and the launch of advanced patient monitoring devices. Nihon Kohden Corp has also expanded its global presence with subsidiaries and sales offices in various countries. With a strong focus on research and development, this esteemed company continues to revolutionize the healthcare industry with its high-quality products and solutions.

Nihon Kohden Corp is a renowned Japanese company specializing in the manufacturing and distribution of medical electronic equipment. Established in 1951, Nihon Kohden has a rich history of innovation and commitment to advancing healthcare. The company has continuously developed cutting-edge technologies for monitoring, diagnosis, and treatment purposes, ranging from patient monitors to electroencephalographs (EEGs) and other medical devices. Nihon Kohden Corp has built a strong global presence over the years, expanding its operations to numerous countries and collaborating with healthcare professionals worldwide. With a focus on delivering reliable and high-quality medical solutions, Nihon Kohden has earned a prominent reputation in the medical industry.

The main competitors of Nihon Kohden Corp in the market include Philips Healthcare, Medtronic, GE Healthcare, and Siemens Healthineers. These companies are prominent players in the healthcare industry, offering a wide range of medical equipment and solutions. Nihon Kohden Corp competes against these companies primarily in the field of patient monitoring and diagnostics. With its advanced technology and dedicated focus on healthcare, Nihon Kohden Corp strives to maintain its competitive position in the market amid these formidable rivals.

Nihon Kohden Corp is primarily active in the healthcare industry.

Nihon Kohden Corp. operates under the business model of manufacturing and distributing medical equipment and systems for patient monitoring and diagnosis purposes. The company specializes in producing a wide range of medical devices, including electrocardiographs, defibrillators, bedside monitors, EEG and EMG systems, and hematology analyzers. Nihon Kohden Corp. aims to provide innovative and reliable medical solutions to healthcare professionals, contributing to the improvement of patient care and outcomes. With its focus on technological advancements and high-quality products, the company has established a strong presence in the global healthcare market.

The Nihon Kohden P/E ratio is 19.11.

The Nihon Kohden P/S ratio is 1.47.

The AlleAktien quality score for Nihon Kohden is 3/10.

The Nihon Kohden revenue is 221.99 B JPY.

The Nihon Kohden profit is 17.03 B JPY.

Nihon Kohden Corporation is a leading global provider of medical technology and system solutions for the diagnosis and treatment of patients. The company was founded in Japan in 1951 and now has branches and subsidiaries in over 80 countries. The business model of Nihon Kohden is divided into various divisions that together offer a wide range of products and comprehensive services for medical care. The core business areas include clinical diagnostics, electrophysiology, cardiac monitoring, intensive care medicine, and neurology. In clinical diagnostics, Nihon Kohden offers a variety of products and systems for laboratory diagnostics, including automation solutions, infection test kits, hemoglobin analyzers, and urine analysis systems. These products are used to enable rapid and accurate diagnosis and thus optimize patient treatment. In the field of electrophysiology, Nihon Kohden provides products for the precise capture, analysis, and treatment of cardiac arrhythmias. This includes ECG systems, long-term monitoring systems, and devices for electrocardiogram analysis, which significantly contribute to making a correct diagnosis and carrying out targeted therapy. For cardiac monitoring and intensive care medicine, Nihon Kohden offers products such as patient monitors, defibrillators, and ventilation devices that are used for monitoring and emergency treatment of critical patients. These devices are crucial for treating life-threatening situations quickly and effectively. In neurology, the company offers products for monitoring and diagnosing brain diseases, including EEG and EMG systems for measuring electrical currents in the brain or muscle tissue, as well as devices for monitoring brain activity during anesthesia. In addition to these main business areas, Nihon Kohden also offers a wide range of services to support the various products and systems. These include training and support for medical staff in the use of the devices, maintenance and repair, as well as consulting and support for the implementation of information technology solutions. Overall, Nihon Kohden's business model is focused on offering a wide range of products and services tailored to the needs of patients and medical professionals. By focusing on various medical fields, the company ensures that it provides comprehensive medical solutions that contribute to improving the quality of healthcare worldwide.

Nihon Kohden pays a dividend of 30 JPY distributed over payouts per year.

The dividend cannot currently be calculated for Nihon Kohden or the company does not pay out a dividend.

The ISIN of Nihon Kohden is JP3706800004.

The WKN of Nihon Kohden is 864378.

The ticker of Nihon Kohden is 6849.T.

Over the past 12 months, Nihon Kohden paid a dividend of 46 JPY . This corresponds to a dividend yield of about 2.37 %. For the coming 12 months, Nihon Kohden is expected to pay a dividend of 51.46 JPY.

The current dividend yield of Nihon Kohden is 2.37 %.

Nihon Kohden pays a quarterly dividend. This is distributed in the months of October, April, October, April.

Nihon Kohden paid dividends every year for the past 23 years.

For the upcoming 12 months, dividends amounting to 51.46 JPY are expected. This corresponds to a dividend yield of 2.65 %.

Nihon Kohden is assigned to the 'Health' sector.

To receive the latest dividend of Nihon Kohden from 12/1/2024 amounting to 15 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

The last dividend was paid out on 12/1/2024.

In the year 2023, Nihon Kohden distributed 71 JPY as dividends.

The dividends of Nihon Kohden are distributed in JPY.